Medication info

Ezetimibe/Simvastatin Tablets 10/20mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
LightPharmTech Co., Ltd.
Appearance
White to pale white, biconvex, rectangular tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Expired

MFDS item code 201906931 · Approved 2019.09.30

This product's status changed to Expired on 2024.09.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, regardless of food intake. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see 1. Warnings in Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, administration of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, section on Patients with Abnormal Liver Function, in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine 10/20mg once daily in the evening. When administering higher doses of this medicine to these patients, use caution and monitor them closely (see 5. General Precautions in Precautions for Use). Administration to elderly patients No dose adjustment is necessary when administering this medicine to elderly patients. Concomitant administration with other medicines (See 6. Interactions in Precautions for Use) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Ingredients

Manufacturer
LightPharmTech Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medicine helps reduce total cholesterol, LDL cholesterol, apoB protein, and triglycerides, and increase the good cholesterol HDL cholesterol in patients with primary hypercholesterolemia and mixed hyperlipidemia as an adjunct to diet therapy. It is especially used as an adjunctive treatment when other therapies are ineffective in patients with homozygous familial hypercholesterolemia. This medicine should be used in conjunction with appropriate dietary therapy, and it is important to identify the cause through expert diagnosis, as other diseases or medications may affect dyslipidemia. Furthermore, patients at high risk of cardiovascular disease should formulate a treatment plan considering multiple risk factors. This medicine is used to effectively control cholesterol levels and improve vascular health.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, regardless of food intake. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see 1. Warnings in Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, administration of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, section on Patients with Abnormal Liver Function, in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine 10/20mg once daily in the evening. When administering higher doses of this medicine to these patients, use caution and monitor them closely (see 5. General Precautions in Precautions for Use). Administration to elderly patients No dose adjustment is necessary when administering this medicine to elderly patients. Concomitant administration with other medicines (See 6. Interactions in Precautions for Use) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Precautions

This medicine is used to lower blood cholesterol levels. Caution should be taken as muscle problems may occur when taking this medicine. If muscle pain or weakness occurs, inform a doctor immediately, and in severe cases, discontinue use. It is safe not to use this medicine in patients with poor liver function or liver disease. Women who are pregnant or breastfeeding should not take this medicine, and women planning to become pregnant should consult a doctor before taking it. There is a risk of muscle damage if this medicine is taken with certain other drugs, so if taking other medications, inform a doctor or pharmacist. Elderly patients or those with decreased renal function also need special caution when taking this medicine. During treatment with this medicine, it is advisable to regularly check liver function and muscle condition through blood tests. Additionally, while taking this medicine, it is safe to avoid certain foods such as grapefruit juice. In case of overdose, there is no specific antidote, so adherence to prescribed dosage is crucial, and if any unusual symptoms occur, visit a medical facility immediately.

Side effects

  • myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 96 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • angioedema
  • rash
  • pancreatitis
  • nausea
  • cholelithiasis
  • cholecystitis
  • asthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • pruritus
  • eczema
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • dysgeusia
  • ophthalmoplegia
  • facial paresis
  • tremor
  • dizziness
  • paresthesia
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorder
  • anxiety
  • sleep disorder
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukocytopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • lethargy
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-glutamyl transferase
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • hepatitis
  • cholestatic jaundice
  • liver steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • loss of appetite
  • vomiting
  • epigastric pain
  • chest pain
  • chest discomfort
  • sensory loss
  • nocturia
  • hematuria
  • weight loss
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to store it at room temperature between 1 degree and 30 degrees Celsius, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

White to pale white, biconvex, rectangular tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.